Intensive systolic blood pressure control

Intervention

1 paper1 finding

  • 1 lab in 1 country
  • Funders: Alzheimer’s Disease Research Center, University of Washington and others
  • 1 of 1 finding with company ties
  • Human trial1

Outcomes

1

Cerebral small vessel disease

downin humans1

1 study
  1. Intensive systolic blood pressure control decreases cerebral small vessel disease in humans (Cohen's d = -0.40 (95% CI, -0.62 to -0.17)).

    Human trialhypertensive adults aged ≥50 years3.9 years

    Intensive versus standard blood pressure control and overall brain small vessel disease burden: a post-hoc analysis of the SPRINT randomized clinical trial

    EClinicalMedicine11 Aug 2026

More on Cerebral small vessel disease

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months